OCE Oncology News
A monthly newsletter for oncology/hematology fellows, junior faculty and scientists
Related Articles
FDA approves nivolumab and hyaluronidase-nvhy for subcutaneous injecti
FDA approves nivolumab and hyaluronidase-nvhy for subcutaneous injection
FDA grants accelerated approval to fam-trastuzumab deruxtecan-nxki for
On April 5, 2024, the Food and Drug Administration granted accelerated approval to fam-trastuzumab deruxtecan-nxki (Enhertu, Daiichi Sankyo, Inc.) for adult patients with unresectable or…
Homepage – Progress for Patients
ProgressForPatients.org, an online advocacy education program and community working to help patients, advocates, and caregivers acquire the necessary tools to effectively communicate with drug researchers,…
The OncoAlert Newsletter is NOW OUT Click to Register
The OncoAlert Newsletter is now out for June 23-29, 2023
The OncoAlert Newsletter is NOW OUT Click to Register
The OncoAlert Newsletter is now out for June 23-29, 2023
Childhood Cancer of the Brain and Other Nervous System – Cancer Stat Facts
Childhood Brain and Other Nervous System Cancer statistics
OCE Conversations on Cancer – Cervical Cancer Treatment Innovation: A Collaborative Discussion
Take this survey powered by surveymonkey.com. Create your own surveys for free.
UV Radiation
Understand the basics about UV radiation and how it damages your skin, learn about the UV index and how to protect against skin cancer.
SEER*Explorer Application
SEER*Explorer provides access to SEER cancer statistics and detailed statistics for a cancer site by gender, race, calendar year, age, and for a selected number…
New surgical and AI techniques for pancreatic cancer
Researchers at the @OSUCCC_James have developed an AI algorithm to identify which pancreatic cysts are likely to develop into cancer, and a less-invasive, organ-saving technique…
